The makers of the vaccine that was given to tens of thousands of people in the US are in negotiations with vaccine manufacturers over its availability in the next few weeks.
The companies are trying to find a solution to the supply chain issue.
The National Institutes of Health has already released a statement saying that the vaccines are available for the time being and will not be affected by the pandemic.
“The vaccine has not been tested on animals and will be available to vaccine recipients in the weeks ahead,” the statement said.
“While the vaccines have been approved for use by many different countries, they have not been approved by the US Food and Drug Administration (FDA).”
As a result, there is uncertainty as to when and how the vaccines will be released to the public.””
In the meantime, manufacturers are trying in good faith to find an acceptable solution for this problem.
“The statement did not mention the vaccine’s manufacturer, GSK.
We expect the FDA to make this a priority. “
We believe that the FDA has a duty to act quickly to ensure that the vaccine is available for all Americans who are at risk of contracting the pandemics disease,” said David Niehaus, chairman of the US Vaccine Advisory Council.
“We expect the FDA to make this a priority.
If this cannot be accomplished, the public deserves an answer.”
The FDA has not said whether it will allow GSK to manufacture vaccines at its facility in Kentucky.
It also has not confirmed the source of the supplies of the drug, which were given to more than 30,000 people.GSK said in a statement that the company was working with the FDA on a “fair, reasonable and timely” solution for the supply issues.”GSK is committed to making vaccine manufacturing available to those in need, as well as ensuring the safety and quality of the drugs and vaccines we deliver,” the company said.GK, which manufactures the vaccine in its factory in Louisville, Kentucky, said it had not been approached by the pharmaceutical company and had not yet been contacted by anyone in the pharmaceutical industry.
The vaccine will be distributed to the US via mail order.
GSK has been distributing the vaccine since July, and has also been working with pharmacies in Canada and Europe to distribute the vaccine.
The company also said it planned to send more than 1 million doses of the shot to hospitals across the US, although it did not specify how many doses.
But the CDC has said the vaccines could not be shipped to hospitals until at least October, when they would be distributed in the state of Georgia.
Gekko’s vaccine has also made headlines.
According to The Associated Press, the drug maker has said it has sent a total of 5,000 doses of its vaccine to US hospitals, but has not received a single case.
Last week, the FDA said it was sending the drug to US pharmacies to ensure the drug is safe.
“There are a number of vaccines currently available for sale to the general public,” the agency said.
“We are working closely with our vaccine manufacturer GSK, who is working to ensure these vaccines are safe for the general population.”
“We are confident that GSK’s vaccines are the safest vaccines available and will receive the highest possible level of scrutiny from the FDA,” it added.
(FRANCE 24 with AP, APTN, AFP)